Green Thumb Industries (GTBIF) Revenue (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Revenue came in at $300.2 million in Q1 2026, up 7.39% YoY from $279.5 million in Q1 2025, and down 3.52% on a QoQ basis from $311.1 million in Q4 2025.
Green Thumb Industries (GTBIF) Revenue (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Revenue data on file, last reported at $300.2 million in Q1 2026.
- Quarterly Revenue rose 7.39% year-over-year to $300.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 4.83% YoY) and the FY2025 annual result came in at $1.2 billion, up 3.36% from the prior year.
- Revenue fell to $300.2 million in Q1 2026, from $311.1 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $311.1 million in Q4 2025 to a low of $242.6 million in Q1 2022.
- A 5-year average of $275.6 million and a median of $278.2 million in 2023 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue climbed 24.77% — and 2023, when it dropped 0.76%.
- Tracing GTBIF's Revenue over 5 years: stood at $259.3 million in 2022, then grew by 7.31% to $278.2 million in 2023, then grew by 5.78% to $294.3 million in 2024, then rose by 5.71% to $311.1 million in 2025, then dropped by 3.52% to $300.2 million in 2026.
- The last three Revenue figures came in at $300.2 million (Q1 2026), $311.1 million (Q4 2025), and $291.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 306.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 306.68 Mn |
| Mar 31, 2026 | 300.19 Mn |
| Dec 31, 2025 | 311.13 Mn |
| Sep 30, 2025 | 291.37 Mn |
| Jun 30, 2025 | 293.26 Mn |
| Mar 31, 2025 | 279.54 Mn |
| Dec 31, 2024 | 294.32 Mn |
| Sep 30, 2024 | 286.87 Mn |
| Jun 30, 2024 | 280.15 Mn |
| Mar 31, 2024 | 275.81 Mn |
| Dec 31, 2023 | 278.23 Mn |
| Sep 30, 2023 | 275.40 Mn |
| Jun 30, 2023 | 252.39 Mn |
| Mar 31, 2023 | 248.54 Mn |
| Dec 31, 2022 | 259.27 Mn |
| Sep 30, 2022 | 261.19 Mn |
| Jun 30, 2022 | 254.31 Mn |
| Mar 31, 2022 | 242.60 Mn |
| Dec 31, 2021 | 243.58 Mn |
| Sep 30, 2021 | 233.68 Mn |